Among the most popular portfolio startups of the fund, we may highlight ExoCoBio. Among the most successful fund investment fields, there are Biotechnology, Cosmetics.
The top activity for fund was in 2017. Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is generally included in less than 2 deals every year.
The usual cause for the fund is to invest in rounds with 4 partakers. The meaningful sponsors for the fund in investment in the same round are SBI Investment, ID Ventures, Atinum Investment. In the next rounds fund is usually obtained by TS Investment, Seven Tree Equity Partners, Quantum Venture Partners.
| Fund Name | Location |
| AMD Ventures | California, Sunnyvale, United States |
| Clinton Group | New York, New York, United States |
| Ei-Publishing | Japan, Tokyo |
| Illumina Ventures | California, Foster City, United States |
| Kompas Gramedia | Indonesia, Jakarta, Jakarta Raya |
| Lenovo Capital and Incubator Group (LCIG) | Beijing, Beijing, China |
| MagnaSci Ventures | - |
| PTV Healthcare Capital | Austin, Texas, United States |
| Qianshi Capital | Beijing, Beijing, China |
| Schon Family Trust | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
AiV | $18M | 05 Aug 2024 | Yongin, Ch'ungch'ong-namdo, South Korea | ||
BIGPICTURE | $11M | 12 Mar 2024 | Seoul, Seoul-t'ukpyolsi, South Korea | ||
ROBOS | $6M | 13 Feb 2024 | Daegu, Taegu-jikhalsi, South Korea | ||
Onconic Therapeutics | $22M | 09 Dec 2022 | Seoul, Seoul-t'ukpyolsi, South Korea | ||
PLANA | $8M | 17 Oct 2022 | Seongnam, Kyonggi-do, South Korea | ||
Atlas Labs | $7M | 07 Sep 2022 | Yeoksamdong, Seoul-t'ukpyolsi, South Korea | ||
Quriously | $8M | 29 Jul 2022 | Seocho, Seoul-t'ukpyolsi, South Korea | ||
Slid | $2M | 21 Jul 2022 | Seoul, Seoul-t'ukpyolsi, South Korea | ||
Allsu | $174K | 14 Jul 2022 | Kyonggi-do, Gyeonggi-do, South Korea |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
AiV | $18M | 05 Aug 2024 | Yongin, Ch'ungch'ong-namdo, South Korea | ||
BIGPICTURE | $11M | 12 Mar 2024 | Seoul, Seoul-t'ukpyolsi, South Korea | ||
ROBOS | $6M | 13 Feb 2024 | Daegu, Taegu-jikhalsi, South Korea | ||
Onconic Therapeutics | $22M | 09 Dec 2022 | Seoul, Seoul-t'ukpyolsi, South Korea | ||
PLANA | $8M | 17 Oct 2022 | Seongnam, Kyonggi-do, South Korea | ||
Atlas Labs | $7M | 07 Sep 2022 | Yeoksamdong, Seoul-t'ukpyolsi, South Korea | ||
Quriously | $8M | 29 Jul 2022 | Seocho, Seoul-t'ukpyolsi, South Korea | ||
Slid | $2M | 21 Jul 2022 | Seoul, Seoul-t'ukpyolsi, South Korea | ||
Allsu | $174K | 14 Jul 2022 | Kyonggi-do, Gyeonggi-do, South Korea |
